Article info
PDFShort report
How practical are transmucosal fentanyl products for breakthrough cancer pain? novel use of placebo formulations to survey user opinion
- Correspondence to Dr Andrew Wilcock, Clinical Reader in Palliative Medicine and Medical Oncology, Honorary Consultant Physician, Macmillan Specialist Palliative Care Unit, University of Nottingham, Nottingham University Hospitals NHS Trust, Hayward House, Nottingham NG5 1PB, UK; andrew.wilcock{at}nottingham.ac.uk
Citation
How practical are transmucosal fentanyl products for breakthrough cancer pain? novel use of placebo formulations to survey user opinion
Publication history
- Accepted August 1, 2011
- First published September 2, 2011.
Online issue publication
August 18, 2016
Article Versions
- Previous version (18 August 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions